6:25 PM
 | 
Dec 12, 2012
 |  BC Extra  |  Company News

MDCO to acquire Incline, partners with BMS

The Medicines Co. (NASDAQ:MDCO) announced a pair of deals on Wednesday, including a deal to acquire Incline Therapeutics Inc. (Redwood City, Calif.) for $185 million up front plus up to $205 million in milestones. The Medicines Co. will gain exclusive, worldwide rights to Ionsys fentanyl, which Incline licensed from the Alza Corp. subsidiary of Johnson & Johnson (NYSE:JNJ) in 2010. The transdermal fentanyl patch was marketed in the EU for short-term management...

Read the full 363 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >